- The FDA authorized Pfizer Inc.’s Paxlovid for high-risk patients 12 and older, making it the first antiviral pill to treat COVID-19 in the United States. Even so, it will likely be months before the pills are widely available. Jeff Zients, coordinator of the White House’s COVID-19 response team, saying the government will have 265,000 courses of the treatment in January and 10 million courses by late summer. (Articles here, here, here, here, here, and here)
December 23, 2021
Life Sciences